Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Boehringer Ingelheim acquires Tyrolean biotech company ViraTherapeutics

© Boehringer Ingelheim

The startup which was spun off from the University of Innsbruck in 2013 focuses on the development of oncolytic viral therapies serving as an immunotherapy in the fight against cancer. "The acquisition strengthens Boehringer Ingelheim's commitment to research and development of viral-based immuno-oncology treatment options for cancer patients", says Boehringer Ingelheim.

The company has already been involved with ViraTherapeutics since 2016 together with EMBL Ventures. ViraTherapeutics will become a separate unit of Boehringer Ingelheim's research organization. 19 researchers are currently employed at the facility in Innsbruck. Up until now the shares in ViraTherapeutics were held by Boehringer Ingelheim Venture Fonds, which acquires stakes in innovative startups in the pharmaceutical sector. 22 young companies are currently in the Boehringer Ingelheim portfolio. Boehringer Ingelheim is very strongly committed to both research and production in Austria. The entire cancer research of the company is bundled in Vienna. At present the Group is investing about EUR 700 million in a new biotech production plant in Vienna.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us in Moscow

    23. - 26.04.2019, Moscow

  • Meet us @ Pioneers

    09. - 10.05.2019, Vienna

Austria Map

Find the perfect location for your company

Thanks to a fantastic mindset, our employees at the Villach site have built up a unique expertise which helps us to further strengthen our position on the global market. We fuse high-performance manufacturing with research and development in the field of power electronics. In addition to a very good cooperation with partners and networks, a well-developed landscape of 'talent factories' ranging from higher technical colleges to universities, we as a company also value the outstanding model of research promotion which exists in Austria.

Infineon

Logo Infineon
More testimonials

news from the business location Austria

Maximize profitability with Vertec

After establishing a subsidiary in Austria in the beginning of 2019, the Swiss software specialist Vertec now operates in the entire DACH region.

Blockchain Technologies: Austria’s Contribution in the Global Race

An international race focusing on the blockchain technology underlying cryptocurrency is currently taking place, not least due to the Bitcoin hype in 2017. Asia and in particular China are a step ahead at present, whereas the USA is somewhat behind. The blockchain industry is still in an embryonic state in large parts of Europe. Find out here why there is still hope and what role Austria is playing.

More news All blog posts